Insiders · ESPR

Jay Shepard

Director at Esperion Therapeutics, Inc. (ESPR)

Jay Shepard has filed 21 insider reports with the SEC since May 2021, as director at Esperion Therapeutics, Inc. (ESPR), director at Ironwood Pharmaceuticals Inc (IRWD) and director at Inovio Pharmaceuticals, Inc. (INO). The latest filing, on July 13, 2026, reports sale back to the company at Esperion Therapeutics, Inc. (ESPR).

Filings
21
Companies
3
Bought on market
None
Sold on market
None

Companies where Jay Shepard is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Esperion Therapeutics, Inc. logo
ESPR
Esperion Therapeutics, Inc.
Director0Jul 13, 2026
Ironwood Pharmaceuticals Inc logo
IRWD
Ironwood Pharmaceuticals Inc
Director235,036$4.87Jun 17, 2026
Inovio Pharmaceuticals, Inc. logo
INO
Inovio Pharmaceuticals, Inc.
Director9,209$1.63May 21, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Jay Shepard with

Other insiders at the same companies

Questions about Jay Shepard

What is Jay Shepard's role at Esperion Therapeutics, Inc.?
Jay Shepard reports to the SEC as director at Esperion Therapeutics, Inc. (ESPR), according to the latest filing on July 13, 2026. Jay Shepard has also filed as director at Ironwood Pharmaceuticals Inc (IRWD) and director at Inovio Pharmaceuticals, Inc. (INO).
How many shares does Jay Shepard own?
After the latest filing that states it, Jay Shepard directly owned 235,036 shares of Ironwood Pharmaceuticals Inc (IRWD) and 9,209 shares of Inovio Pharmaceuticals, Inc. (INO). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Jay Shepard bought or sold stock recently?
No open-market purchases or sales by Jay Shepard are on file. The filings report sale back to the company, grant or award and exercise or conversion of a derivative.
How do I get alerts when Jay Shepard files?
Follow Jay Shepard on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Jay Shepard (SEC CIK 0001587788). Totals count each trade once, skipping amendments whose original is on file, from May 28, 2021 on. View on SEC EDGAR